-
ORIC® Pharmaceuticals Provides Operational Highlights for 2025 and Anticipated Upcoming Milestones
12 Jan 2026 13:30 GMT
… , 2026 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a … event. About ORIC Pharmaceuticals, Inc.
ORIC Pharmaceuticals is a clinical stage … reliance on third parties, including contract manufacturers and contract research organizations; ORIC’s …
-
Asimov and AGC Biologics Team Up to Provide a Cost-Effective, Simplified, and Secure Manufacturing Approach for Viral Vector Production
12 Jan 2026 12:32 GMT
… a leading global biopharmaceutical Contract Development and Manufacturing Organization (CDMO) with a … , advanced therapies, small molecule active pharmaceutical ingredients, and agrochemicals. To learn …
-
ANI Pharmaceuticals Highlights Significant Growth in 2025, Provides 2026 Financial Guidance, and Outlines Strategic Priorities
12 Jan 2026 11:50 GMT
… reported results. About ANI Pharmaceuticals, Inc. ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) … for our raw materials, active pharmaceutical ingredients, expedients, and other … on single source third party contract manufacturing supply for certain of our …
-
Inspire Medical Systems, Inc. Announces Preliminary Unaudited Revenue Results for the Fourth Quarter and Full Year 2025 and Provides Initial 2026 Revenue Guidance
12 Jan 2026 11:45 GMT
… commercialize; competitive companies, technologies and pharmaceuticals in our industry; our involvement … third-party suppliers, vendors, and contract manufacturers; consolidation in the healthcare industry …
-
Blue Mountain welcomes investment from Five Arrows to fuel continued growth
12 Jan 2026 15:05 GMT
… , medical devices, and contract manufacturing industries to ensure compliance while … of European life sciences manufacturing and regulations, uniquely positions … pharmaceutical, biotech, cell & gene therapy, medical device, and contract manufacturing …
-
Trelleborg Exhibits Innovations and Solutions for Medical Components and Devices at MD&M West
12 Jan 2026 15:00 GMT
… advanced solutions for medical devices, pharmaceutical and biotech applications at MD … well as the requirements of contract manufacturers."
Further highlights include solutions …
-
Cabaletta Bio Announces 2026 Strategic Priorities
12 Jan 2026 13:00 GMT
Registrational myositis trial actively enrolling with planned 17-patient cohort and 2027 rese-cel BLA submission – including an outpatient dosing option using a single weight-based dose IND amendment cleared to manufacture rese-cel with the automated, …
-
Bionano Reports Preliminary Fourth Quarter and Full-Year 2025 Results
12 Jan 2026 13:00 GMT
SAN DIEGO, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO) today reported certain unaudited preliminary financial results and commercial highlights for the fourth quarter and fiscal year ended December 31, 2025. “2025 was a pivotal …
-
HHS-OIG Issues Favorable Opinion on Vaccine Manufacturer Offering Upfront Discounts and Rebates to Customers for Vaccines
09 Jan 2026 06:40 GMT
… off the list price or contract price for a vaccine, with … off the list price or contract price for multiple vaccines where … all price reporting requirements for pharmaceutical manufacturers under all federal and state …
-
Lehi's Civica to supply generic medicines under contract with VA
09 Jan 2026 04:14 GMT
… Federal Supply Schedule contract by the U.S … contract, Civica’s products will be available for purchase through the Pharmaceutical … manufacture low-cost generic medicines, then work with payers, pharmacy … the value chain from manufacturing through dispensing — …
About
© 1995-2026